Acumen Pharmaceuticals
acumenpharm.comLocations
Carmel, IN, USA · Charlottesville, VA, USA · West Street / River Street, Boston, MA, USA
industry
Pharmaceuticals
Size
51-200 employees
Stage
IPO
founded in
1996
Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers. Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (ABO) in synaptic dysfunction and neurodegeneration. These early insights have fostered decades of research on the biology of ABO at Acumen and throughout the field. We are now on the cusp of realizing the therapeutic potential of ABO targeted drugs.
Something looks off?Open jobs at Acumen Pharmaceuticals
On-site & Remote
Seniority
Salary